CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 90 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2020. The put-call ratio across all filers is 0.13 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $74,256,000 | +0.3% | 627,111 | 0.0% | 28.61% | +41.6% |
Q4 2020 | $74,068,000 | -24.5% | 627,111 | -28.9% | 20.20% | -63.1% |
Q3 2020 | $98,071,000 | +1.2% | 882,411 | -7.0% | 54.82% | +40.2% |
Q2 2020 | $96,931,000 | -3.2% | 948,629 | +2.2% | 39.10% | +50.7% |
Q1 2020 | $100,161,000 | +59.5% | 928,016 | +72.0% | 25.94% | +28.5% |
Q4 2019 | $62,798,000 | +145.6% | 539,597 | +141.5% | 20.20% | +119.8% |
Q3 2019 | $25,573,000 | +77.7% | 223,400 | +47.9% | 9.19% | +21.7% |
Q2 2019 | $14,394,000 | -4.1% | 151,034 | -8.2% | 7.55% | -26.8% |
Q1 2019 | $15,011,000 | +24.2% | 164,500 | +3.3% | 10.32% | -32.0% |
Q4 2018 | $12,085,000 | +5.4% | 159,200 | +11.1% | 15.18% | +35.9% |
Q3 2018 | $11,464,000 | – | 143,300 | – | 11.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VERNIER CAPITAL PARTNERS, LP | 137,557 | $11,142,000 | 6.62% |
COMGEST GLOBAL INVESTORS S.A.S. | 637,752 | $51,658,000 | 1.13% |
Black Creek Investment Management Inc. | 411,525 | $33,334,000 | 1.09% |
Hillhouse Capital Management | 618,391 | $50,090,000 | 0.88% |
RUDMAN ERROL M | 21,301 | $1,725,000 | 0.83% |
JUPITER ASSET MANAGEMENT LTD | 263,705 | $21,360,000 | 0.65% |
York Capital Management Global Advisors, LLC | 341,616 | $27,671,000 | 0.62% |
VONTOBEL ASSET MANAGEMENT INC | 873,968 | $71,525,000 | 0.51% |
Temasek Holdings (Private) Ltd | 990,000 | $80,190,000 | 0.44% |
WASATCH ADVISORS LP | 292,216 | $23,669,000 | 0.31% |